These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11439459)

  • 1. The role of cholecystokinin in conditional compensatory responding and morphine tolerance in rats.
    Kim JA; Siegel S
    Behav Neurosci; 2001 Jun; 115(3):704-9. PubMed ID: 11439459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of endogenous cholecystokinin in tolerance to morphine antinociception in the nucleus accumbens of rats.
    Xiong W; Yu LC
    Behav Brain Res; 2006 Oct; 173(1):116-21. PubMed ID: 16837074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A locus and mechanism of action for associative morphine tolerance.
    Mitchell JM; Basbaum AI; Fields HL
    Nat Neurosci; 2000 Jan; 3(1):47-53. PubMed ID: 10607394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraadministration associations: conditional hyperalgesia elicited by morphine onset cues.
    Sokolowska M; Siegel S; Kim JA
    J Exp Psychol Anim Behav Process; 2002 Jul; 28(3):309-20. PubMed ID: 12136706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin is necessary for the expression of morphine conditioned place preference.
    Mitchell JM; Bergren LJ; Chen KS; Fields HL
    Pharmacol Biochem Behav; 2006 Dec; 85(4):787-95. PubMed ID: 17196636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
    Tortorici V; Nogueira L; Salas R; Vanegas H
    Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chronic naltrexone pretreatment on associative vs. non-associative morphine tolerance.
    Azorlosa JL
    Drug Alcohol Depend; 1994 Aug; 36(1):65-7. PubMed ID: 7988361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
    Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.
    Panerai AE; Rovati LC; Cocco E; Sacerdote P; Mantegazza P
    Brain Res; 1987 Apr; 410(1):52-60. PubMed ID: 3580899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
    Hoffmann O; Wiesenfeld-Hallin Z
    Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
    Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D
    Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to the hyperthermic effect of morphine in the rat is a learned response.
    Siegel S
    J Comp Physiol Psychol; 1978 Dec; 92(6):1137-49. PubMed ID: 755060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-onset cues as signals: intraadministration associations and tolerance.
    Kim JA; Siegel S; Patenall VR
    J Exp Psychol Anim Behav Process; 1999 Oct; 25(4):491-504. PubMed ID: 10531660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors.
    Veraksits A; Rünkorg K; Kurrikoff K; Raud S; Abramov U; Matsui T; Bourin M; Kõks S; Vasar E
    Psychopharmacology (Berl); 2003 Mar; 166(2):168-75. PubMed ID: 12545332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid expectation modifies opioid effects.
    Siegel S
    Fed Proc; 1982 May; 41(7):2339-43. PubMed ID: 7075793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.
    Phillips GD; Le Noury J; Wolterink G; Donselaar-Wolterink I; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Jun; 55(2):223-31. PubMed ID: 8357529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin.
    Faris PL; McLaughlin CL; Baile CA; Olney JW; Komisaruk BR
    Science; 1984 Dec; 226(4679):1215-7. PubMed ID: 6505689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
    Zarrindast MR; Nikfar S; Rezayat M
    Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
    McNally GP; Westbrook RF
    Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.
    Xu XJ; Puke MJ; Verge VM; Wiesenfeld-Hallin Z; Hughes J; Hökfelt T
    Neurosci Lett; 1993 Apr; 152(1-2):129-32. PubMed ID: 8515864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.